Human Neural Stem Cells

BIOLOGICAL2 trials

Sponsors

Azienda Ospedaliera Santa Maria, Terni, Italy, Casa Sollievo della Sofferenza IRCCS

Conditions

Amyotrophic Lateral SclerosisSecondary-progressive Multiple Sclerosis

Phase 1

Human Neural Stem Cell Transplantation in Amyotrophic Lateral Sclerosis (ALS)

CompletedNCT01640067

Azienda Ospedaliera Santa Maria, Terni, ItalyAmyotrophic Lateral Sclerosis

Start: 2011-12-31End: 2015-12-31Updated: 2015-12-30

Safety Study of Human Neural Stem Cells Injections for Secondary Progressive Multiple Sclerosis Patients

CompletedNCT03282760

Casa Sollievo della Sofferenza IRCCSSecondary-progressive Multiple Sclerosis

Start: 2017-09-09End: 2021-05-29Updated: 2021-07-12

Related Papers

Phase I clinical trial of intracerebroventricular transplantation of allogeneic neural stem cells in people with progressive multiple sclerosis.

2023-11-2725 citations

Human Neural Stem Cell-Based Drug Product: Clinical and Nonclinical Characterization

International Journal of Molecular Sciences2022-11-0313 citations

Culturing and Expansion of "Clinical Grade" Neural Stem Cells from the Fetal Human Central Nervous System.

2022-01-014 citations

Transplantation of clinical-grade human neural stem cells reduces neuroinflammation, prolongs survival and delays disease progression in the SOD1 rats

Cell Death and Disease2019-04-2542 citations